Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Monday 22 March 2010 9:13 pm

Wall Street rises after healthcare bill is passed

By: KCS-content

Add as a preferred source on Google

US stocks advanced yesterday, boosted by gains in the healthcare sector as passage of a bill to overhaul the system eased uncertainty for investors.

The legislation was passed by the US House of Representatives late on Sunday, and while analysts have raised concerns it will pinch corporate profits, they said much of the negative impact was priced in already.

Also, hospital and drug companies could likely benefit from the bill. Pfizer, the world’s largest drug company, rose two per cent to $17.25.

“It could also be just a sigh of relief that it’s over with and nothing worse is coming. The market is showing its colours here in the face of what should have been an opening decline this morning,” said Stephen Massocca, managing director, Wedbush Morgan in San Francisco.

The Dow Jones industrial average was up 32.80 points, or 0.31 per cent, at 10,774.78. The Standard & Poor’s 500 Index was up 3.49 points, or 0.30 per cent, at 1,163.39. The Nasdaq Composite Index was up 13.01 points, or 0.55 per cent, at 2,387.42.

The Morgan Stanley Healthcare Payor Index gained 1.2 per cent, putting it on track for a sixth straight session of gains. Insurer

Health Plans rose 1.8 per cent to $31.27. The debate over Greece’s fiscal woes heated up. A EC official pressed Germany to agree on a financial safety net.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Money

Related Topics

  • NULL

Trending Articles

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • James Watt offers to buy back Brewdog

  • Bank of England warns Burnham of UK economy’s ‘big issue’

  • The former African gold miner taking on the billionaire Issa brothers

  • Rachel Reeves to unveil next steps for ring-fencing reform at Mansion House

More from City PM

  • Regulator wins decade-long pricing tussle with Pfizer

    Legal
    Hikma reported a jump in profit for 2024
  • House of Lords lashes out at Labour for ‘eliminating’ its oversight of financial watchdogs

    Regulation
    House of Lords chamber during debate on Employment Rights Bill, highlighting Labours setback on workers rights legislation
  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech
    GSK said total sales fell by two per cent in the third quarter
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Boots eyes £7.5bn sale in blow to hopes of London IPO

    Retail
    Boots remains one of the group’s best performing business lines, with a London float suggested as recently as last year. (Photo by Oli Scarff/Getty Images)
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Thames Water, energy grid, rent prices: Burnham drums up public control agenda

    Politics
    Burnham skyline at sunset highlighting modern architecture against a vibrant orange and pink sky, reflecting urban develop...
  • AI infrastructure boom helps power Halma to record sales and profit

    Tech
    Halma's revenue was boosted by its environmental and safety businesses.

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook